Integrum AB

Equities

INTEG B

SE0009807266

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm Other stock markets 12:00:00 2024-06-20 pm EDT			5-day change	1st Jan Change
53.4 ^SEK	+1.52%		+2.30%	+16.98%

Jun. 13	Integrum AB Signs Memorandum of Understanding with Coapt, LLC for the Use of its Pattern Recognition Technology with the e-OPRA[TM] Implant System	CI
Jun. 10	Integrum AB Enters Collaboration and Distribution Agreement with Hanger	CI

Integrum AB Announces Chief Executive Officer Changes

May 19, 2022 at 12:22 pm EDT

Integrum AB (publ) announced the Board of Directors has appointed Rickard Brånemark as CEO of the company. Brånemark is the founder and main owner of Integrum AB and was CEO between 1998-2015. Previous Chief Executive Officer Maria Elena Lopez, will continue to support the company during the termination period.

Latest news about Integrum AB

Integrum AB Signs Memorandum of Understanding with Coapt, LLC for the Use of its Pattern Recognition Technology with the e-OPRA[TM] Implant System	Jun. 13	CI
Integrum AB Enters Collaboration and Distribution Agreement with Hanger	Jun. 10	CI
Integrum AB Reports Earnings Results for the Fourth Quarter and Full Year Ended April 30, 2024	May. 29	CI
Integrum Receives Market Approval for Opra®? Implant System in Israel	May. 29	CI
Integrum Announces It Has Been Granted A Registered Trademark for OPRA® Implant System in the Eu	May. 15	CI
Integrum Expands Its Product Offering to the United Kingdom Market	May. 02	CI
Integrum Enters a Commercial agreement with AMI Technologies to introduce the OPRATM Implant System in Israel	Mar. 26	CI
Integrum AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	Feb. 28	CI
Integrum Sells and Delivers Opratm Implant Systems to A Value of SEK 3.5 Million to Center of Excellence in Ukraine	Jan. 31	CI
Integrum AB Establishes Center of Excellence in Ukraine	Dec. 20	CI
Integrum AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	Dec. 03	CI
Integrum AB Plans to Submit a PMA Application to the FDA for the Use of OPRA in Transhumeral Implantations Based on Existing Clinical Data	Nov. 13	CI
Integrum AB Provides Earnings Guidance for the Second Quarter of 2023	Nov. 10	CI
Integrum Announces US Department of Defense Decided to Fully Fund a Clinical Study of OPRA(TM) Implant System on Up to 30 Patients with Transtibial (Below-Knee) Amputations	Nov. 10	CI
Integrum's Opra?? Implant System Gets Fda Approval for Clinical Study on Below-Knee Amutationations	23-10-30	CI
Integrum Enters into the Turkey Market	23-10-27	CI
Integrum Announces Long-Term Follow-Up Patient Who Received A Human-Machine Bionic Hand Prosthesis, Utilizing	23-10-12	CI
Integrum Announces Long-Term Integrated Bionic Hand Enriched with Motor and Sensory AI	23-10-12	CI
Integrum Receives Unitary Patent for Neuromotus in the EU	23-10-10	CI
Integrum AB Appoints Scott Flora as Full Board Member	23-10-10	CI
Integrum Initiates A Strategic Review Process to Accelerate Growth	23-09-14	CI
Integrum AB Receives Reimbursement Code for Axor II	23-09-08	CI
Integrum AB Reports Earnings Results for the First Quarter Ended July 31, 2023	23-08-30	CI
Analysis-Small firms offer private equity job market bright spot	23-07-26	RE
Integrum Announces First Case Study of A Person with Above-Elbow Implantation Obtains Unprecedented Control of Every Finger in A Bionic Hand	23-07-13	CI

Chart Integrum AB

Duration

Period

More charts

Company Profile

Integrum AB is a Sweden-based company within healthcare sector. It provides systems for bone-anchored prostheses for individuals with amputations. The Companyâs solutions comprise OPRA Implant System, neural prosthetics, phantom limb pain treatment and prosthetic components. The OPRA implant system is based on osseointegration, enabling the direct connection of an artificial limb to the skeleton. The neural prosthetics technology implies ability to directly connect bionic prostheses to the patientâs bone, nerves, and muscles. A method for limb pain treatment implies motor execution of the phantom limb as a treatment, which is aided by machine learning, augmented and virtual reality. The Company provides a variety of prosthetic components required to connect the OPRA Implant System to external prostheses.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-28 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Integrum AB

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Prosthetics

	1st Jan change	Capi.
INTEGRUM AB	+16.98%	98.26M
STRAUMANN HOLDING AG	-19.99%	19.34B
SONOVA HOLDING AG	-1.17%	18.08B
COCHLEAR LIMITED	+8.85%	14.12B
DEMANT A/S	+3.18%	9.52B
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.	-22.16%	1.94B
EMBLA MEDICAL HF.	-0.18%	1.68B
MODERN DENTAL GROUP LIMITED	+1.63%	530M
ANGEL ROBOTICS CO., LTD.	0.00%	385M
DELCATH SYSTEMS, INC.	+93.75%	224M

Medical Prosthetics